ECIA
Price
$0.35
Change
-$0.00 (-0.00%)
Updated
Dec 17 closing price
50 days until earnings call
QTRX
Price
$10.33
Change
-$0.78 (-7.02%)
Updated
Dec 18, 04:59 PM (EDT)
76 days until earnings call
Ad is loading...

ECIA vs QTRX

Header iconECIA vs QTRX Comparison
Open Charts ECIA vs QTRXBanner chart's image
Encision
Price$0.35
Change-$0.00 (-0.00%)
Volume$1K
CapitalizationN/A
Quanterix
Price$10.33
Change-$0.78 (-7.02%)
Volume$6.18K
CapitalizationN/A
ECIA vs QTRX Comparison Chart
Loading...
ECIA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QTRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ECIA vs. QTRX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ECIA is a Hold and QTRX is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (ECIA: $0.35 vs. QTRX: $11.11)
Brand notoriety: ECIA and QTRX are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ECIA: 4% vs. QTRX: 118%
Market capitalization -- ECIA: $5.41M vs. QTRX: $907.82M
ECIA [@Medical Specialties] is valued at $5.41M. QTRX’s [@Medical Specialties] market capitalization is $907.82M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ECIA’s FA Score shows that 1 FA rating(s) are green whileQTRX’s FA Score has 1 green FA rating(s).

  • ECIA’s FA Score: 1 green, 4 red.
  • QTRX’s FA Score: 1 green, 4 red.
According to our system of comparison, both ECIA and QTRX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ECIA’s TA Score shows that 3 TA indicator(s) are bullish while QTRX’s TA Score has 4 bullish TA indicator(s).

  • ECIA’s TA Score: 3 bullish, 3 bearish.
  • QTRX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ECIA is a better buy in the short-term than QTRX.

Price Growth

ECIA (@Medical Specialties) experienced а -12.50% price change this week, while QTRX (@Medical Specialties) price change was -5.69% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.17%. For the same industry, the average monthly price growth was +1.60%, and the average quarterly price growth was -0.66%.

Reported Earning Dates

ECIA is expected to report earnings on Feb 06, 2025.

QTRX is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Medical Specialties (-4.17% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
QTRX($908M) has a higher market cap than ECIA($5.41M). ECIA YTD gains are higher at: -17.647 vs. QTRX (-59.364). ECIA has higher annual earnings (EBITDA): -529.03K vs. QTRX (-39.79M). QTRX has more cash in the bank: 321M vs. ECIA (120K). ECIA has less debt than QTRX: ECIA (976K) vs QTRX (41.5M). QTRX has higher revenues than ECIA: QTRX (121M) vs ECIA (7.15M).
ECIAQTRXECIA / QTRX
Capitalization5.41M908M1%
EBITDA-529.03K-39.79M1%
Gain YTD-17.647-59.36430%
P/E Ratio47.17N/A-
Revenue7.15M121M6%
Total Cash120K321M0%
Total Debt976K41.5M2%
FUNDAMENTALS RATINGS
ECIA vs QTRX: Fundamental Ratings
ECIA
QTRX
OUTLOOK RATING
1..100
9164
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
33
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9692
PRICE GROWTH RATING
1..100
8080
P/E GROWTH RATING
1..100
5100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

QTRX's Valuation (33) in the Pharmaceuticals Major industry is somewhat better than the same rating for ECIA (69) in the null industry. This means that QTRX’s stock grew somewhat faster than ECIA’s over the last 12 months.

QTRX's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as ECIA (100) in the null industry. This means that QTRX’s stock grew similarly to ECIA’s over the last 12 months.

QTRX's SMR Rating (92) in the Pharmaceuticals Major industry is in the same range as ECIA (96) in the null industry. This means that QTRX’s stock grew similarly to ECIA’s over the last 12 months.

QTRX's Price Growth Rating (80) in the Pharmaceuticals Major industry is in the same range as ECIA (80) in the null industry. This means that QTRX’s stock grew similarly to ECIA’s over the last 12 months.

ECIA's P/E Growth Rating (5) in the null industry is significantly better than the same rating for QTRX (100) in the Pharmaceuticals Major industry. This means that ECIA’s stock grew significantly faster than QTRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ECIAQTRX
RSI
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
79%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
N/A
Bullish Trend 10 days ago
83%
Declines
ODDS (%)
N/A
Bearish Trend 6 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
66%
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
ECIA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QTRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GCEDX8.33N/A
N/A
Goldman Sachs Clean Energy Income Ins
HBLTX15.13N/A
N/A
Hartford Balanced Income R5
PGEMX25.62-0.10
-0.39%
George Putnam Balanced M
HAOSX13.48-0.08
-0.59%
Harbor International Core Institutional
SCRSX12.59-0.15
-1.18%
Bernstein Small Cap Core SCB

ECIA and

Correlation & Price change

A.I.dvisor tells us that ECIA and RDNT have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ECIA and RDNT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ECIA
1D Price
Change %
ECIA100%
N/A
RDNT - ECIA
26%
Poorly correlated
-1.87%
QTRX - ECIA
24%
Poorly correlated
-2.63%
SEMHF - ECIA
23%
Poorly correlated
-0.31%
HBIO - ECIA
23%
Poorly correlated
+1.40%
BFLY - ECIA
21%
Poorly correlated
-2.22%
More

QTRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, QTRX has been loosely correlated with SIBN. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if QTRX jumps, then SIBN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QTRX
1D Price
Change %
QTRX100%
-2.63%
SIBN - QTRX
47%
Loosely correlated
+0.51%
LUNG - QTRX
47%
Loosely correlated
-1.13%
MASS - QTRX
45%
Loosely correlated
-5.58%
CTKB - QTRX
42%
Loosely correlated
-2.28%
BLFS - QTRX
40%
Loosely correlated
-1.83%
More